Familial Mediterranean fever occurring in an elderly Japanese woman with recent-onset rheumatoid arthritis

Intern Med. 2013;52(3):385-8. doi: 10.2169/internalmedicine.52.9102. Epub 2013 Feb 1.

Abstract

A 60-year-old woman with a two-year history of rheumatoid arthritis (RA) developed recurrent two- to three-day attacks of fever (>38 °C) accompanied by monoarthritis of the right hip joint. The first attack occurred two months after beginning anti-tumor necrosis factor-α therapy. Since a diagnosis of infectious arthritis was suspected, the therapy was discontinued. Thereafter, the patient repeated similar episodes; however, oral colchicine effectively controlled the attacks. The patient was diagnosed to have familial Mediterranean fever (FMF). The clinical manifestations of FMF mimic infectious complications during anti-RA therapy. Clinicians should therefore consider the possibility of FMF development in RA patients exhibiting recurrent febrile attacks.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / adverse effects
  • Antirheumatic Agents / adverse effects
  • Arthritis, Infectious / diagnosis
  • Arthritis, Rheumatoid / complications*
  • Arthritis, Rheumatoid / therapy
  • Colchicine / therapeutic use
  • Cytoskeletal Proteins / genetics
  • Diagnostic Errors
  • Familial Mediterranean Fever / complications*
  • Familial Mediterranean Fever / diagnosis
  • Familial Mediterranean Fever / drug therapy
  • Female
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Infliximab
  • Magnetic Resonance Imaging
  • Methotrexate / adverse effects
  • Middle Aged
  • Mutation
  • Pyrin
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Cytoskeletal Proteins
  • Immunosuppressive Agents
  • MEFV protein, human
  • Pyrin
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Colchicine
  • Methotrexate